Search results
Corrado Tamburino
Job title: Professor and Chief of Cardiothoracic, Transplantation and Vascular Surgery Department
Author
Ardawan Julian Rastan
Job title: Staff Cardiac Surgeon at the Department of Cardiac Surgery
Author
Steven Promislow
Job title: Cardiologist
Author
Author(s):
Michelle Kittleson
Added:
1 year ago
ESC 2024 - We are joined by Dr Michelle Kittleson (Cedars-Sinai Heart Institute, US) for a concise and insightful summary of the hot-line and late-breaking data that is expected to have an impact on heart failure care.Trials covered in detail include:FINEARTS HFHELIOS-BRESHAPE HF2Recorded remotely from Los Angeles, 2024.Editors: Jordan Rance and Mirjam Boros.Videographers: Mike Knight, Dan Brent,…
View more
Start date:
Feb 25, 2025
End date:
Feb 26, 2025
Due to the recent success of New Horizons in Amyloidosis, Radcliffe Cardiology are excited to introduce a new 2-day event ‘New Horizons in Cardiomyopathy’ (NHC) in February 2025.The event, hosted on Radcliffe Cardiology, will be streamed on Tuesday 25 February - Wednesday 26February 2025. It promises an interactive and informative experience, updating professionals on cardiac amyloidosis and…
View more
John Sapp
Job title: Clinical Cardiac Electrophysiologist
Author
Nayef Al-Asiri
Job title: Consultant interventional cardiologist (Cardiac center )
Author
Author(s):
Ahmad Masri
Added:
9 months ago
HFSA 25 - Aficamten found to significantly improve NYHA and KCCQ-CSS scores in new 96-week data from FOREST-HCM.Dr Ahmad Masri (Oregon Health & Science University, US) joins us to discuss findings from the FOREST-HCM trial, examining the sustained safety and efficacy of aficamten in patients with symptomatic nonobstructive hypertrophic cardiomyopathy.This phase 2 open-label study followed 34…
View more
Maurizio Lunati
Author